Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2014

Jul 29, 2014

30597_dirs_2014-07-29_ffdd5027-52da-47cf-9d57-34914ae48fc0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2013-10-31

Reporting Person: LIDGARD GRAHAM PETER (Sr. VP, Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-31 Common Stock A 436 $7.81 Acquired 103073 Direct
2014-04-30 Common Stock A 791 $7.81 Acquired 103864 Direct
2014-07-25 Common Stock M 25000 Acquired 128864 Direct
2014-07-25 Common Stock S 11081 $15.99 Disposed 117783 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-25 Restricted Stock Units $ M 25000 Disposed Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11395 Indirect

Footnotes

F1: Represents shares purchased through Employee Stock Purchase Plan.

F2: Represents shares of common stock received upon vesting of a restricted stock unit award.

F3: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on July 25, 2014.

F4: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5: Represents a restricted stock unit award granted on July 25, 2013 that partially vested on July 25, 2014. The restricted stock units vest in three equal annual installments beginning on July 25, 2014.